
# Title 21— FOOD AND DRUGS
### CHAPTER 9— FEDERAL FOOD, DRUG, AND COSMETIC ACT
#### § 356c. Discontinuance or interruption in the production of life-saving drugs
##### (h) Definitions

For purposes of this section

(1) the term “drug”

(A) means a drug (as defined in section 321(g) of this title ) that is intended for human use and that is subject to section 353(b)(1) of this title ; and

(B) does not include biological products (as defined in section 262 of title 42 ), unless otherwise provided by the Secretary in the regulations promulgated under subsection (i);

(2) the term “drug shortage” or “shortage”, with respect to a drug, means a period of time when the demand or projected demand for the drug within the United States exceeds the supply of the drug; and

(3) the term “meaningful disruption”

(A) means a change in production that is reasonably likely to lead to a reduction in the supply of a drug by a manufacturer that is more than negligible and affects the ability of the manufacturer to fill orders or meet expected demand for its product; and

(B) does not include interruptions in manufacturing due to matters such as routine maintenance or insignificant changes in manufacturing so long as the manufacturer expects to resume operations in a short period of time.
